Passage Bio (PASG) Income Statement: Revenue & Earnings

Passage Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Passage Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	40.18	61.42	83.75	117.67	82.79
Selling, General & Administrative	24.99	41.58	45.54	60.06	30.11
Operating Expenses	65.17	103.00	129.29	177.73	112.90
Operating Income	-65.17	-103.00	-129.29	-177.73	-112.90
Other Income/Expense
Interest Income	4.30	5.60	2.30	3.12	1.30
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.40	0.94	-0.03	-0.34	0.00
Income
Income Before Tax	-64.77	-102.06	-136.13	-185.39	-112.23
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-64.77	-102.06	-136.13	-185.39	-112.23
Net Income - Continuous Operations	-64.77	-102.06	-136.13	-185.39	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-62.09	-99.28	-125.62	-176.19	-111.10
EBIT	-65.17	-103.00	-129.29	-177.73	-111.90
Depreciation & Amortization	3.08	3.72	3.68	1.54	0.80
Earnings Per Share
Basic EPS	-21.00	-37.00	-50.00	-70.00	-3.00
Diluted EPS	-21.00	-37.00	-50.00	-70.00	-3.00
Basic Shares Outstanding	3.02	2.74	2.72	2.67	38.62
Diluted Shares Outstanding	3.02	2.74	2.72	2.67	38.62